Media & Analysis
3 Q&A interviews with MVA-membersContact person
3 Q&A Interview with Duane Mancini, CEO Project Medtech
From an international and US perspective, why do you find the Medicon Valley cluster interesting? The Medicon Valley cluster is fascinating as a successful model of cross-border collaboration, demonstrating how shared goals and geographical proximity can create a powerful innovation hub for others...
3 Q&A interview with Mark Daly, Senior Business Development Manager at Almac Group
1. How do you believe Almac Clinical Services can contribute to the continued success of Medicon Valley and Medicon Valley based companies? With Almac Clinical Services, we believe that our commitment to “Supply with Care” is perfectly aligned with supporting the continued growth and innovation of...
3 Q&A interview with Flavio Lisboa, COO Nordika, Advance Engineering
Q1: Designing GMP facilities can be a big challenge to both clients, engineering, and construction firms. Short deadlines, market demands – from the client side - and strong regulatory constrains are only a few to mention. How does Nordika contributes for a smooth path throughout a GMP project...
3 Q&A Interview with Stephan Gheysen, Partner, Advokat / Attorney LL.M. MVA-member 360 Law Firm
Q1: What Makes 360 Law Firm Unique Compared to Other Law Firms? At 360 Law Firm, we take pride in being different from other law firms. What sets us apart is the time and resources we invest in truly understanding our clients and their businesses. We believe legal advice should be delivered in a...
3 Q&A interview with Carmen Mak, Sales Manager, Camida
1) How can Camida contribute to life science in the Danish-Swedish Medicon Valley region? Camida is a customer service-driven supplier of specialised raw materials to the Life Sciences industry, globally. Our dedicated team can make a significant contribution to the life science sector in the...
3 Q&A interview with Sanna Wallenborg, PhD, CEO Lumito
1) What is the key relevance of your patented technology for digital pathology tissue Our technology and solution deliver high quality tissue images that enable researchers in the field of for example digital pathology, drug development and drug discovery to see/detect lower amounts of...
3 Q&A interview with Kristina Thored, Vice President CDMO, MVA member Galenica
1) What are the key advantages to being in the Swedish-Danish Medicon Valley region? Galenica was founded in Malmö in 1999, at a time when the area was dominated by larger pharmaceutical companies but lacked the presence of a more agile and specialized CDMO. With the growth of the Medicon Valley...
3 Q&A interview with Karri Nieminen, Business Development Director, Europe, new MVA member SanaClis
1) How do you think SanaClis can contribute to the Medicon Valley life science ecosystem? SanaClis can significantly contribute to the Medicon Valley life science ecosystem by leveraging our capabilities as a full-service Global CRO. We are also one of the few service providers with an extensive...
3 Q&A interview with Emma Guilhou, Business Development Manager at MVA member, GTP Bioways
1) What are the unique features of GTP Bioways? GTP Bioways, a French CDMO with more than 20 years’ experience, provides one-stop-shop services to biopharma companies. From late-stage discovery through preclinical and clinical trials to market readiness, we provide seamless support across the...
3 Q&A interview with Client Director, Stuart Schofield, new MVA member Mannaz
Q1) With regards to leadership, what are some of the pressing industry specific challenges for the life science industry? Global healthcare expenditure is growing, leading to surging R&D investments, with new modalities and digital acceleration taking pace. For leaders in the pharmaceutical...